• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Harmony Biosciences Holdings Inc (NQ: HRMY )

    35.62 -0.53 (-1.47%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 139,384
    Open 36.10
    Bid (Size) 32.00 (1)
    Ask (Size) 39.00 (1)
    Prev. Close 36.15
    Today's Range 35.36 - 36.10
    52wk Range 18.61 - 39.27
    Shares Outstanding 56,834,745
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript
    HRMY earnings call for the period ending June 30, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Analyst Expectations For Harmony Biosciences's Future
    Via Benzinga

    Performance

    YTD
    +15.69%
    +15.69%
    1 Month
    +5.32%
    +5.32%
    3 Month
    +21.07%
    +21.07%
    6 Month
    +9.70%
    +9.70%
    1 Year
    +3.85%
    +3.85%

    More News

    Read More
    HRMY Stock Earnings: Harmony Biosciences Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
    From Harmony Biosciences
    Via GlobeNewswire
    7 Cheap Biotech Stocks With Major Upside Potential
    Via InvestorPlace
    A Glimpse Into The Expert Outlook On Harmony Biosciences Through 7 Analysts
    Via Benzinga
    Key Takeaways From Harmony Biosciences Analyst Ratings
    Via Benzinga
    Evaluating Harmony Biosciences: Insights From 8 Financial Analysts
    Via Benzinga
    7 Undervalued Biotech Stocks to Buy for Big-Time Returns
    Via InvestorPlace
    7 Biotech Stocks to Buy on the Dip: June 2024
    Via InvestorPlace
    Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Analyst Ratings For Harmony Biosciences
    Via Benzinga
    NASDAQ:HRMY stands out as a growth opportunity that won't break the bank.
    Via Chartmill
    Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
    From Harmony Biosciences
    Via GlobeNewswire
    Updates: HRMY, MELI, SWAV
    Via Talk Markets
    Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
    From Harmony Biosciences
    Via GlobeNewswire
    The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
    Via InvestorPlace
    The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
    Via InvestorPlace
    NASDAQ:HRMY: good value for what you're paying.
    Via Chartmill
    Investors should take notice of NASDAQ:HRMY—it offers a great deal for the fundamentals it presents.
    Via Chartmill
    Why Harmony Biosciences Stock Got Slammed Today
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.